Skip to content

Rosalind Advisors, Inc.

Follow

13F filer, CIK 1622627, TORONTO, Ontario, Canada

Rosalind Advisors, Inc. reported $311,878,275 across 46 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 72.24% of the portfolio.

Accepted , ingested 13F-HR 0001622627-26-000034

Period
2026-09-30
Reported value
$312M
Holdings
46
Top 10 weight
72.24%
New
15
Sold out
4

Part of the filer group Rosalind Advisors, Inc.

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • MEDIWOUND LTD: 13G/A 1,312,319 shares, 9.1% of the class, 13G/A filed 2026-11-13, 0001622627-26-000029
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
REPLnew+1,000,000$13.2M
AQSTadded+1,750,000$8.1M
TARAnew+2,400,000$7.32M
RCKTnew+2,200,000$5.79M
PEPGadded+1,650,000$3.99M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CLDXexited-200,000-$7.44M
HELPreduced-568,845-$6.99M
AVIRreduced-790,489-$4.12M
XERSreduced-326,334-$3.12M
PCVXreduced-50,639-$2.88M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001622627-26-000034, largest first. % of portfolio is the value over $309,255,660, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,650,389 shares; 2025Q1: 2,900,389 shares; 2025Q2: 3,300,389 shares; 2025Q3: 3,300,389 shares; 2025Q4: 3,300,389 shares; 2026Q1: 3,300,389 shares; 2026Q2: 3,300,389 shares; 2026Q3: 3,300,389 shares 3,300,389$52.7M17.04%02026-10-13, 13D/A: No share count stated, 13D/A filed 2026-10-19 Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 900,000 shares; 2025Q1: 2,644,517 shares; 2025Q2: 2,043,563 shares; 2025Q3: 1,929,563 shares; 2025Q4: 1,788,475 shares; 2026Q1: 2,138,475 shares; 2026Q2: 3,986,509 shares; 2026Q3: 4,236,509 shares 4,236,509$34.1M11.03%+250,000Timeline
FENCFENNEC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,259,876 shares; 2025Q1: 1,782,844 shares; 2025Q2: 2,045,644 shares; 2025Q3: 2,076,840 shares; 2025Q4: 2,613,508 shares; 2026Q1: 2,908,201 shares; 2026Q2: 3,188,001 shares; 2026Q3: 3,188,001 shares 3,188,001$34M10.98%0Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,104,995 shares; 2025Q1: 2,495,986 shares; 2025Q2: 2,155,594 shares; 2025Q3: 1,795,766 shares; 2025Q4: 2,111,700 shares; 2026Q1: 3,231,700 shares; 2026Q2: 2,908,981 shares; 2026Q3: 2,582,647 shares 2,582,647$24.7M7.98%-326,334Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 810,918 shares; 2025Q1: 810,918 shares; 2025Q2: 810,918 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,657,540 shares; 2026Q1: 1,531,814 shares; 2026Q2: 1,956,814 shares; 2026Q3: 1,387,969 shares 1,387,969$17.1M5.52%-568,845Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,654,944 shares; 2025Q1: 2,654,944 shares; 2025Q2: 2,654,944 shares; 2025Q3: 4,000,000 shares; 2025Q4: 3,403,721 shares; 2026Q1: 3,203,721 shares; 2026Q2: 3,178,121 shares; 2026Q3: 3,178,121 shares 3,178,121$16.4M5.3%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 260,000 shares; 2025Q1: 850,000 shares; 2025Q2: 900,000 shares; 2025Q3: not reported; 2025Q4: 1,410,497 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000$13.2M4.28%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 700,000 shares; 2026Q2: 648,600 shares; 2026Q3: 609,199 shares 609,199$11.6M3.76%-39,401Timeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 628,050 shares; 2025Q1: 506,893 shares; 2025Q2: 407,061 shares; 2025Q3: 749,054 shares; 2025Q4: 749,054 shares; 2026Q1: 749,054 shares; 2026Q2: 749,054 shares; 2026Q3: 749,054 shares 749,054$10.3M3.34%0Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,544,607 shares; 2025Q4: 2,605,920 shares; 2026Q1: 3,214,766 shares; 2026Q2: 3,214,766 shares; 2026Q3: 3,214,766 shares 3,214,766$9.32M3.01%0Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 2,000,000 shares 2,000,000$9.26M2.99%+1,750,000Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 290,000 shares; 2026Q2: 200,000 shares; 2026Q3: 149,361 shares 149,361$8.5M2.75%-50,639Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,400,000 shares 2,400,000$7.32M2.37%newTimeline
MYOMYOMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,998,945 shares; 2025Q1: 2,703,661 shares; 2025Q2: 3,595,788 shares; 2025Q3: 3,790,788 shares; 2025Q4: 3,839,772 shares; 2026Q1: 3,847,272 shares; 2026Q2: 3,637,886 shares; 2026Q3: 3,917,886 shares 3,917,886$6.11M1.98%+280,000Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 923,057 shares; 2026Q2: 721,504 shares; 2026Q3: 721,504 shares 721,504$6.01M1.94%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,200,000 shares 2,200,000$5.79M1.87%newTimeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 350,000 shares; 2026Q3: 2,000,000 shares 2,000,000$4.84M1.57%+1,650,000Timeline
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 692,185 shares; 2025Q1: 692,185 shares; 2025Q2: 692,185 shares; 2025Q3: 692,185 shares; 2025Q4: 1,068,955 shares; 2026Q1: 828,118 shares; 2026Q2: 828,118 shares; 2026Q3: 828,118 shares 828,118$4.8M1.55%0Timeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 613,939 shares; 2025Q1: 2,003,939 shares; 2025Q2: 2,003,939 shares; 2025Q3: 4,385,757 shares; 2025Q4: 3,579,273 shares; 2026Q1: 3,353,916 shares; 2026Q2: 5,169,501 shares; 2026Q3: 4,134,144 shares 4,134,144$4.8M1.55%-1,035,357Timeline
NRXSNEURAXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 286,138 shares; 2026Q1: 286,138 shares; 2026Q2: 508,055 shares; 2026Q3: 548,123 shares 548,123$4.04M1.31%+40,068Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,107,994 shares; 2026Q2: 1,107,994 shares; 2026Q3: 1,107,994 shares 1,107,994$2.76M0.89%0Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,495,783 shares; 2025Q1: 2,274,990 shares; 2025Q2: 2,289,099 shares; 2025Q3: 3,905,743 shares; 2025Q4: 3,905,743 shares; 2026Q1: 3,905,743 shares; 2026Q2: 3,905,743 shares; 2026Q3: 3,905,743 shares 3,905,743$2.62M0.85%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,100,000 shares 1,100,000$2.44M0.79%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 650,000 shares; 2025Q4: 690,000 shares; 2026Q1: 1,036,737 shares; 2026Q2: 988,230 shares; 2026Q3: 695,977 shares 695,977$2.28M0.74%-292,253Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,869 shares; 2026Q3: 20,869 shares 20,869$2.07M0.67%0Timeline
BFRIBIOFRONTERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 811,918 shares; 2025Q1: 644,393 shares; 2025Q2: 976,448 shares; 2025Q3: 1,140,764 shares; 2025Q4: 1,140,764 shares; 2026Q1: 1,163,962 shares; 2026Q2: 1,275,609 shares; 2026Q3: 1,789,288 shares 1,789,288$1.93M0.62%+513,679Timeline
FEMYFEMASYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 759,213 shares 759,213$1.64M0.53%newTimeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,171,855 shares; 2026Q2: 1,070,550 shares; 2026Q3: 280,061 shares 280,061$1.46M0.47%-790,489Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 192,974 shares; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 100,000 shares; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$1.42M0.46%newTimeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 26,517 shares 26,517$1.29M0.42%+6,517Timeline
RGNTREGENTIS BIOMATERIALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 251,510 shares; 2026Q1: 251,510 shares; 2026Q2: 701,685 shares; 2026Q3: 701,685 shares 701,685$1.27M0.41%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$1.07M0.35%0Timeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 476,190 shares 476,190$1.02M0.33%newTimeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,018,021 shares; 2025Q1: 1,018,021 shares; 2025Q2: 975,462 shares; 2025Q3: 918,668 shares; 2025Q4: 696,556 shares; 2026Q1: 597,926 shares; 2026Q2: 389,455 shares; 2026Q3: 177,011 shares 177,011$933K0.3%-212,444Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 730,488 shares; 2026Q1: 443,763 shares; 2026Q2: 150,000 shares; 2026Q3: 67,506 shares 67,506$184K0.06%-82,494Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPDR SERIES TRUSTSPDR SERIES TRUST PUTput250,000$925K+109,400
STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T PUTput100,000$382Knew
VERASTEM INCVERASTEM INC COM NEWcall293,600$357Knew
INVESCO QQQ TRINVESCO QQQ TR PUTput50,000$258Knew
PEPGEN INCPEPGEN INC CALLcall412,700$257Knew
XERIS BIOPHARMA HOLDINGS INCXERIS BIOPHARMA HOLDINGS INC COMcall400,000$160Knew
SELLAS LIFE SCIENCES GROUP ISELLAS LIFE SCIENCES GROUP I PUTput618,800$127K+50,100
BRISTOL-MYERS SQUIBB COBRISTOL-MYERS SQUIBB CO CALLcall20,000$84.2Knew
EYEPOINT INCEYEPOINT INC CALLcall701,700$50K+651,400
CORCEPT THERAPEUTICS INCCORCEPT THERAPEUTICS INC COMput10,000$23.5Knew
CELLDEX THERAPEUTICS INC NEWCELLDEX THERAPEUTICS INC NEW COM NEWput128,800$0new

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CLDXCELLDEX THERAPEUTICS INC NEW200,000$7.44Mshares
CG ONCOLOGY INCCG ONCOLOGY INC31,000$375Kcall
ISHARES TRISHARES TR500,000$110Kput
TENAX THERAPEUTICS INCTENAX THERAPEUTICS INC6,200$13.9Kput

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001622627-26-000034 base2026-11-16